2021-2022 Regular SessionDelaware Legislature

HB219: An Act To Amend Title 18 Of The Delaware Code Relating To Pharmacy Benefits Managers.

Legislative Summary

Over 80% of pharmaceuticals in the United States are purchased through pharmacy benefits manager ("PBM") networks. PBMs serve as intermediaries between health plans, pharmaceutical manufacturers, and pharmacies or pharmacists, and PBMs establish networks for patients to receive reimbursement for drugs. Given the scope of PBMs in the healthcare delivery system, this Act is designed to provide enhanced oversight and transparency as it relates to PBMs.

Demographic Impact

Overall analysis of equity impact

80% Positive
Medium ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

6/3/2021
Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
6/9/2021
Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 3 Favorable, 8 On Its Merits
6/17/2021
Passed By House. Votes: 41 YES
6/17/2021
Assigned to Banking, Business & Insurance Committee in Senate
6/23/2021
Reported Out of Committee (Banking, Business & Insurance) in Senate with 2 Favorable, 4 On Its Merits
6/29/2021
Passed By Senate. Votes: 21 YES
10/26/2021
Enact w/o Sign by Governor

Roll Call Votes

Senate Third Reading
6/29/2021
21
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
House Third Reading
6/17/2021
41
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED